Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study

BackgroundBreakthrough cancer pain (BTCP) is a transient exacerbation of pain that affects the length of hospitalization and quality of life of patients. The objective of this study was to determine the prevalence and factors associated with BTCP among cancer patients at oncology units in Northern E...

Full description

Bibliographic Details
Main Authors: Yohanes Tekie, Yonas Addisu Nigatu, Wudie Mekonnen, Yophtahe Woldegerima Berhe
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1248921/full
_version_ 1797360311193305088
author Yohanes Tekie
Yonas Addisu Nigatu
Wudie Mekonnen
Yophtahe Woldegerima Berhe
author_facet Yohanes Tekie
Yonas Addisu Nigatu
Wudie Mekonnen
Yophtahe Woldegerima Berhe
author_sort Yohanes Tekie
collection DOAJ
description BackgroundBreakthrough cancer pain (BTCP) is a transient exacerbation of pain that affects the length of hospitalization and quality of life of patients. The objective of this study was to determine the prevalence and factors associated with BTCP among cancer patients at oncology units in Northern Ethiopia in 2022.MethodsA multi-center cross-sectional study was conducted from April to June 2022. After obtaining ethical approval, data were collected prospectively from 424 adult cancer patients admitted to oncology units. Breakthrough cancer pain was assessed by the numeric rating scale. Descriptive and binary logistic regression analyses were performed to determine the factors associated with BTCP. The strength of association was described in adjusted odds ratio (AOR) with 95% confidence intervals and variables with a P-value < 0.05 were considered to have a statistically significant association with BTCP.ResultThe prevalence of BTCP among cancer patients was 41.5%. The factors that were found to be associated with BTCP were colorectal cancer (AOR: 7.7, 95% CI: 1.8, 32.3), lung cancer (AOR: 6.9, 95% CI: 1.9, 26.0), metastasis (AOR: 9.3, 95% CI: 3.0, 29.1), mild background pain (AOR: 7.5, 95% CI: 2.5, 22.6), moderate background pain (AOR: 7.0, 95% CI: 2.2, 23.1), severe background pain (AOR: 7.1, 95% CI: 2.2, 22.8), no analgesics taken for background pain (AOR: 5.1, 95% CI: 2.8, 9.3) and uncontrolled background pain (AOR: 3.3, 95% CI: 1.8, 6.1).ConclusionThe prevalence of BTCP was high. Colorectal cancer, lung cancer, the presence of metastasis, the presence of background pain, not taking analgesics for background pain, and uncontrolled background pain were significantly associated with BTCP.
first_indexed 2024-03-08T15:36:29Z
format Article
id doaj.art-5e8d59daab47403994c307a9bc63af32
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-08T15:36:29Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-5e8d59daab47403994c307a9bc63af322024-01-09T18:28:25ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-01-011310.3389/fonc.2023.12489211248921Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center studyYohanes Tekie0Yonas Addisu Nigatu1Wudie Mekonnen2Yophtahe Woldegerima Berhe3Department of Anesthesia, Aksum University, Aksum, EthiopiaDepartment of Anesthesia, University of Gondar, Gondar, EthiopiaDepartment of Anesthesia, University of Gondar, Gondar, EthiopiaDepartment of Anesthesia, University of Gondar, Gondar, EthiopiaBackgroundBreakthrough cancer pain (BTCP) is a transient exacerbation of pain that affects the length of hospitalization and quality of life of patients. The objective of this study was to determine the prevalence and factors associated with BTCP among cancer patients at oncology units in Northern Ethiopia in 2022.MethodsA multi-center cross-sectional study was conducted from April to June 2022. After obtaining ethical approval, data were collected prospectively from 424 adult cancer patients admitted to oncology units. Breakthrough cancer pain was assessed by the numeric rating scale. Descriptive and binary logistic regression analyses were performed to determine the factors associated with BTCP. The strength of association was described in adjusted odds ratio (AOR) with 95% confidence intervals and variables with a P-value < 0.05 were considered to have a statistically significant association with BTCP.ResultThe prevalence of BTCP among cancer patients was 41.5%. The factors that were found to be associated with BTCP were colorectal cancer (AOR: 7.7, 95% CI: 1.8, 32.3), lung cancer (AOR: 6.9, 95% CI: 1.9, 26.0), metastasis (AOR: 9.3, 95% CI: 3.0, 29.1), mild background pain (AOR: 7.5, 95% CI: 2.5, 22.6), moderate background pain (AOR: 7.0, 95% CI: 2.2, 23.1), severe background pain (AOR: 7.1, 95% CI: 2.2, 22.8), no analgesics taken for background pain (AOR: 5.1, 95% CI: 2.8, 9.3) and uncontrolled background pain (AOR: 3.3, 95% CI: 1.8, 6.1).ConclusionThe prevalence of BTCP was high. Colorectal cancer, lung cancer, the presence of metastasis, the presence of background pain, not taking analgesics for background pain, and uncontrolled background pain were significantly associated with BTCP.https://www.frontiersin.org/articles/10.3389/fonc.2023.1248921/fullbreakthrough paincancer paincancerpainbreakthrough cancer pain (BTCP)
spellingShingle Yohanes Tekie
Yonas Addisu Nigatu
Wudie Mekonnen
Yophtahe Woldegerima Berhe
Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study
Frontiers in Oncology
breakthrough pain
cancer pain
cancer
pain
breakthrough cancer pain (BTCP)
title Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study
title_full Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study
title_fullStr Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study
title_full_unstemmed Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study
title_short Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study
title_sort breakthrough pain among cancer patients at oncology units in northern ethiopia a multi center study
topic breakthrough pain
cancer pain
cancer
pain
breakthrough cancer pain (BTCP)
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1248921/full
work_keys_str_mv AT yohanestekie breakthroughpainamongcancerpatientsatoncologyunitsinnorthernethiopiaamulticenterstudy
AT yonasaddisunigatu breakthroughpainamongcancerpatientsatoncologyunitsinnorthernethiopiaamulticenterstudy
AT wudiemekonnen breakthroughpainamongcancerpatientsatoncologyunitsinnorthernethiopiaamulticenterstudy
AT yophtahewoldegerimaberhe breakthroughpainamongcancerpatientsatoncologyunitsinnorthernethiopiaamulticenterstudy